Ovarian cancer stem cell biology and chemoresistance

This publication has 152 references indexed in Scilit:

• The determinants of tumour immunogenicity
  Nature Reviews Cancer, 2012
• Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells
  Cancer Cell, 2012
• Maintenance of muscle stem-cell quiescence by microRNA-489
  Nature, 2012
• Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome
  Experimental and Molecular Pathology, 2011
• Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells
  International Journal of Cancer, 2011
• Clinical significance of side population in ovarian cancer cells
  Human Cell, 2011
• Efficient tumour formation by single human melanoma cells
  Nature, 2008
• Hematopoietic Stem Cell Quiescence Is Maintained by Compound Contributions of the Retinoblastoma Gene Family
  Cell Stem Cell, 2008
• CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
  British Journal of Cancer, 2008
• Multidrug resistance in cancer: role of ATP–dependent transporters
  Nature Reviews Cancer, 2002